World Congress on Precision Biotherapeutics - 2026
Bridging Bioconjugates, RNA Therapeutics & Precision Medicine. Serving as the premier global platform for scientists, clinicians, industry leaders, and regulators to accelerate targeted breakthrough therapies.
The World Congress on Precision Biotherapeutics (WCPB 2026) is dedicated to advancing precision biotherapeutics by fostering innovation, multidisciplinary collaboration, and translating discoveries into safe, accessible targeted therapies.
The Scientific Committee invites researchers, clinicians, healthcare experts, and students to submit original scientific abstracts for oral, poster, and industry innovation presentations.
WCPB 2026 features 8 specialized scientific tracks covering precision biotherapeutics, translational research, therapeutic platforms, manufacturing, and emerging computational discovery.
Affiliation
Pioneer in site-specific antibody conjugation technologies and next-generation clinical translation.
Affiliation
Specialist in nanomedicine delivery kinetics and lipid nanoparticle (LNP) formulation for mRNA transport.
Affiliation
Keynote address on next-generation bioconjugates and clinical translation breakthroughs.
Affiliation
Keynote address on AI proteomic modeling and in silico targeted drug design.
Interactive forum for researchers to present cutting-edge biotherapeutic work, exchange ideas, and engage with global scientists, clinicians, and industry leaders.
Register to attend WCPB 2026. Tiered fee structure for Speakers, Delegates, Poster Presenters, and Students with early bird savings.
Partner with WCPB 2026 to showcase your biopharmaceutical technologies, analytical instrumentation, and drug discovery platforms.